A comprehensive view of u.s. food and drug administration (fda). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Emergent BioSolutions receives exclusive global rights to Chimerix’s oral brincidofovir, including Tembexa, an FDA-approved medical countermeasure for smallpox, for US$325M; Chimerix in negotiations with BARDA for Tembexa procurement contract
Published: May 20, 2022 by Marketline - Deals
FDA denies petitions to ban phthalates from food packaging and food production equipment; meanwhile, the agency will request new information regarding safety assessment for food-contact uses of phthalates
Published: May 19, 2022 by Earthjustice
CDC considers expanding COVID-19 booster eligibility to people under 50 as cases rise to 94,000 per day, with seven-day case average rising 26% from the previous week and hospitalizations up 19% to 3,000 per day; additional dose requires FDA approval
Published: May 19, 2022 by Reuters
Lupin Pharmaceuticals issues US recall of 3.3 million bottles of Losartan potassium tables, 3.9 million bottles of Losartan potassium and hydrochlorothiazide due to current good manufacturing practices; drugs made at Lupin's Madhya Pradesh, India, plant
Published: May 18, 2022 by Accord Fintech
FDA lifts clinical hold on Gilead’s injectable lenacapavir HIV treatment, pre-exposure prophylaxis as Gilead changes borosilicate glass vials to aluminosilicate glass vials; hold was from concerns about drug’s compatibility with borosilicate vials
Published: May 18, 2022 by Zack's Commentary

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count